These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8277183)

  • 1. Primary influenza A virus infection induces cross-reactive antibodies that enhance uptake of virus into Fc receptor-bearing cells.
    Gotoff R; Tamura M; Janus J; Thompson J; Wright P; Ennis FA
    J Infect Dis; 1994 Jan; 169(1):200-3. PubMed ID: 8277183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses.
    Tamura M; Webster RG; Ennis FA
    J Virol; 1994 Jun; 68(6):3499-504. PubMed ID: 8189489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry.
    Tamura M; Webster RG; Ennis FA
    Virology; 1991 May; 182(1):211-9. PubMed ID: 2024464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel H6N1 virus-like particle vaccine induces long-lasting cross-clade antibody immunity against human and avian H6N1 viruses.
    Yang JR; Chen CY; Kuo CY; Cheng CY; Lee MS; Cheng MC; Yang YC; Wu CY; Wu HS; Liu MT; Hsiao PW
    Antiviral Res; 2016 Feb; 126():8-17. PubMed ID: 26593980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
    He W; Tan GS; Mullarkey CE; Lee AJ; Lam MM; Krammer F; Henry C; Wilson PC; Ashkar AA; Palese P; Miller MS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11931-11936. PubMed ID: 27698132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children.
    Steinhoff MC; Fries LF; Karron RA; Clements ML; Murphy BR
    J Clin Microbiol; 1993 Apr; 31(4):836-8. PubMed ID: 8463393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
    Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
    N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.
    Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
    J Infect Dis; 1986 Jul; 154(1):121-7. PubMed ID: 3711685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity to influenza virus infection induced by heterologous, inactivated vaccines.
    Potter CW; Jennings R; Nicholson K
    Med Microbiol Immunol; 1978 Nov; 166(1-4):99-108. PubMed ID: 723794
    [No Abstract]   [Full Text] [Related]  

  • 11. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
    He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
    J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human monoclonal antibodies neutralizing influenza virus A/H1N1pdm09 and seasonal A/H1N1 strains - Distinct Ig gene repertoires with a similar action mechanism.
    Hiroi S; Kuhara M; Kishi Y; Ono KI; Matsuzawa S; Yamamoto N; Komano J
    Immunobiology; 2018 Mar; 223(3):319-326. PubMed ID: 29107382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.
    Wang Z; Chua BY; Ramos JV; Parra SM; Fairmaid E; Brown LE; Jackson DC; Kedzierska K
    Vaccine; 2015 Sep; 33(39):5148-54. PubMed ID: 26277069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
    Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
    Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccine immunology.
    Dormitzer PR; Galli G; Castellino F; Golding H; Khurana S; Del Giudice G; Rappuoli R
    Immunol Rev; 2011 Jan; 239(1):167-77. PubMed ID: 21198671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inactivated influenza vaccine (H1N1, H3N2, H3N1) - antibody response and protective effect in the influenza epidemic H1N1 in 1979 (author's transl)].
    Bruj J; Skocil V; Farník J; Hronovský F; Síp J
    Cesk Epidemiol Mikrobiol Imunol; 1981 Sep; 30(5):287-93. PubMed ID: 6456837
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells.
    Hashimoto G; Wright PF; Karzon DT
    J Infect Dis; 1983 Nov; 148(5):785-94. PubMed ID: 6605395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.